Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/34388
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18074/20272 (89%)
Visitors : 2434314      Online Users : 1056
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34388


    Title: Sugammadex induced bradycardia and hypotension A case report and literature review
    Authors: Teng, I-Chia
    Chang, Ying-Jen
    Lin, Yao-Tsung
    Chu, Chin-Chen
    Chen, Jen-Yin
    Wu, Zhi-Fu
    Contributors: Chi Mei Med Ctr, Dept Anesthesiol
    Chia Nan Univ Pharm & Sci, Dept Food Sci & Technol
    Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Anesthesiol
    Tri Serv Gen Hosp
    Natl Def Med Ctr, Dept Anesthesiol
    Keywords: bradycardia
    cardiac arrest
    hypotension
    sugammadex
    Date: 2021
    Issue Date: 2023-11-11 11:48:52 (UTC+8)
    Publisher: LIPPINCOTT WILLIAMS & WILKINS
    Abstract: Rationale: There is evidence that sugammadex can facilitate extubation post-surgery and attenuate postoperative pulmonary complications resulting from postoperative residual neuromuscular blockade. However, it may induce adverse effects, including bronchospasm, laryngospasm, bradycardia, hypotension, and cardiac arrest. Here, we present a case of sugammadex-induced bradycardia and hypotension. Patient concerns: An 82-year-old female received video-assisted thoracic surgery decortication and wedge resection of the lung for empyema. Post-surgery, she developed bradycardia, hypotension, hypoxia, and weakness. Diagnoses: The patient was suspected to have sugammadex-induced bradycardia, hypotension, hypoxia and weakness. Interventions: The patient received immediate treatment with atropine (0.5 mg) for bradycardia. Glycopyrrolate (0.1 mg) and neostigmine (1 mg) were administered to improve the train-of-four (TOF) ratio. Outcomes: Following initial management, we observed improvement in the hemodynamics of the patient. She was discharged without any sequelae. Lessons: Sugammadex-induced bradycardia or cardiac arrest are rare; however, anesthesiologists must consider the possibility of the occurrence of such events and initiate appropriate management measures. Immediate treatment with atropine and inotropic or vasopressors is warranted if the patient presents with bradycardia.
    Relation: MEDICINE, v.100, n.30
    Appears in Collections:[Dept. of Food Science & Technology] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML163View/Open
    MD.0000000000026796.pdf209KbAdobe PDF68View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback